190 related articles for article (PubMed ID: 27020088)
21. Diagnostic and Prognostic Biomarkers for Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Kalariya N; Bowe C; Dains JE
Oncol Nurs Forum; 2020 Mar; 47(2):E35-E43. PubMed ID: 32078615
[TBL] [Abstract][Full Text] [Related]
22. Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease.
Crossland RE; Perutelli F; Bogunia-Kubik K; Mooney N; Milutin Gašperov N; Pučić-Baković M; Greinix H; Weber D; Holler E; Pulanić D; Wolff D; Dickinson AM; Inngjerdingen M; Grce M
Front Immunol; 2020; 11():602547. PubMed ID: 33424849
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo.
Wang XX; Wang QQ; Wu JQ; Jiang M; Chen L; Zhang CF; Xiang LH
Br J Dermatol; 2016 Jun; 174(6):1318-26. PubMed ID: 26801009
[TBL] [Abstract][Full Text] [Related]
24. Biomarkers in chronic graft-versus-host disease: quo vadis?
Wolff D; Greinix H; Lee SJ; Gooley T; Paczesny S; Pavletic S; Hakim F; Malard F; Jagasia M; Lawitschka A; Hansen JA; Pulanic D; Holler E; Dickinson A; Weissinger E; Edinger M; Sarantopoulos S; Schultz KR
Bone Marrow Transplant; 2018 Jul; 53(7):832-837. PubMed ID: 29367715
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
Pavletic SZ; Smith LM; Bishop MR; Lynch JC; Tarantolo SR; Vose JM; Bierman PJ; Hadi A; Armitage JO; Kessinger A
Am J Hematol; 2005 Apr; 78(4):265-74. PubMed ID: 15795914
[TBL] [Abstract][Full Text] [Related]
26. Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells.
Bonanni V; Antonangeli F; Santoni A; Bernardini G
J Immunother Cancer; 2019 Nov; 7(1):290. PubMed ID: 31699153
[TBL] [Abstract][Full Text] [Related]
27. Plasma CXCL9 elevations correlate with chronic GVHD diagnosis.
Kitko CL; Levine JE; Storer BE; Chai X; Fox DA; Braun TM; Couriel DR; Martin PJ; Flowers ME; Hansen JA; Chang L; Conlon M; Fiema BJ; Morgan R; Pongtornpipat P; Lamiman K; Ferrara JL; Lee SJ; Paczesny S
Blood; 2014 Jan; 123(5):786-93. PubMed ID: 24363401
[TBL] [Abstract][Full Text] [Related]
28. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
29. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
[TBL] [Abstract][Full Text] [Related]
30. Analysis of cysteine-X-cysteine motif chemokine ligands 9, 10, and 11, their receptor CXCR3, and their possible role on the recruitment of immune cells at the maternal-conceptus interface in pigs.
Han J; Gu MJ; Yoo I; Choi Y; Jang H; Kim M; Yun CH; Ka H
Biol Reprod; 2017 Jul; 97(1):69-80. PubMed ID: 28859287
[TBL] [Abstract][Full Text] [Related]
31. Shaping of CD56
Ni M; Wang L; Yang M; Neuber B; Sellner L; Hückelhoven-Krauss A; Schubert ML; Luft T; Hegenbart U; Schönland S; Wuchter P; Chen BA; Eckstein V; Krüger W; Yerushalmi R; Beider K; Nagler A; Müller-Tidow C; Dreger P; Schmitt M; Schmitt A
Front Immunol; 2019; 10():547. PubMed ID: 30949182
[TBL] [Abstract][Full Text] [Related]
32. Association of Plasma CD163 Concentration with De Novo-Onset Chronic Graft-versus-Host Disease.
Inamoto Y; Martin PJ; Paczesny S; Tabellini L; Momin AA; Mumaw CL; Flowers MED; Lee SJ; Carpenter PA; Storer BE; Hanash S; Hansen JA
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1250-1256. PubMed ID: 28455006
[TBL] [Abstract][Full Text] [Related]
33. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
34. CD19+CD21low B cells and CD4+CD45RA+CD31+ T cells correlate with first diagnosis of chronic graft-versus-host disease.
Greinix HT; Kuzmina Z; Weigl R; Körmoczi U; Rottal A; Wolff D; Kralj M; Kalhs P; Mitterbauer M; Rabitsch W; Edinger M; Holler E; Pickl WF
Biol Blood Marrow Transplant; 2015 Feb; 21(2):250-8. PubMed ID: 25460358
[TBL] [Abstract][Full Text] [Related]
35. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
36. Buyang Huanwu Decoction Attenuates Infiltration of Natural Killer Cells and Protects Against Ischemic Brain Injury.
Dou B; Zhou W; Li S; Wang L; Wu X; Li Y; Guan H; Wang C; Zhu S; Ke Z; Huang C; Wang Z
Cell Physiol Biochem; 2018; 50(4):1286-1300. PubMed ID: 30355926
[TBL] [Abstract][Full Text] [Related]
37. [Detection of NK and NKT cells in peripheral blood of patients with cGVHD and its significance].
Zhou MH; Wang CM; Gong CP; Luo Y; Zhang M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1167-70. PubMed ID: 23114141
[TBL] [Abstract][Full Text] [Related]
38. National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution.
Lawitschka A; Gueclue ED; Januszko A; Körmöczi U; Rottal A; Fritsch G; Bauer D; Peters C; Greinix HT; Pickl WF; Kuzmina Z
Front Immunol; 2019; 10():1879. PubMed ID: 31507582
[TBL] [Abstract][Full Text] [Related]
39. Elevated numbers of immature/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease.
Greinix HT; Pohlreich D; Kouba M; Körmöczi U; Lohmann I; Feldmann K; Zielinski C; Pickl WF
Biol Blood Marrow Transplant; 2008 Feb; 14(2):208-19. PubMed ID: 18215781
[TBL] [Abstract][Full Text] [Related]
40. Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?
Duraković N; Krečak I; Perić Z; Milošević M; Desnica L; Pulanić D; Pusic I; Kušec V; Vrhovac R; Pavletic SZ; Nemet D
Croat Med J; 2016 Jun; 57(3):239-46. PubMed ID: 27374825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]